$VSTM What will Roche do if CH/ DEFACTINIB may become a block buster Combo drug? 🎯🚀 In October 2002, Chugai merged with Nippon Roche based on a strategic alliance agreement with Roche, one of the world’s leading pharmaceutical companies, and Roche acquired a majority of Chugai’s stock. Chugai became a member of the Roche Group. Roche was established in 1896 and headquartered in Basel, Switzerland, “Roche is the No. 1 pharmaceutical company in the world by revenues”, with business operations in more than 150 countries. The Roche Group contributes to medicine through its two business segments of pharmaceuticals and diagnostics. Roche holds 59.9% of Chugai’s outstanding shares based on the strategic alliance agreement!